Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Retirement planning is essential for achieving financial stability in your later years. Learn why it's never too early to start planning.
21,478 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
SBI Holdings moves to launch Japan's first spot XRP ETF, prioritizing XRP over Ethereum due to regulatory fit and a d...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
Toyo’s Q1 2026 earnings kick off a pivotal year for the company. This article breaks down the numbers, the commentary...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...
A senior comms exec says AI notetakers are moving from convenience to liability as governance gaps and confidential n...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
The Midwest is powering America’s spring housing rebound as demand returns and listings climb. A new Realtor.com repo...
SpaceX finally opened its doors to public markets, signaling a pivotal moment for growth investors. This guide breaks...
Investors are shifting away from speculative hydrogen plays toward a blue-chip, high-yield industrial stock. Here’s w...